Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Primary Hyperparathyroidism and Gut Microbiota

View source ↗

Summary

A clinical trial evaluating the relationship between primary hyperparathyroidism and gut microbiota has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Hyperparathyroidism, Primary | Status: TERMINATED